vs

Side-by-side financial comparison of Acadian Asset Management Inc. (AAMI) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $172.2M, roughly 1.1× Acadian Asset Management Inc.). Acadian Asset Management Inc. runs the higher net margin — 20.2% vs 6.7%, a 13.4% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 2.6%). Over the past eight quarters, Acadian Asset Management Inc.'s revenue compounded faster (27.6% CAGR vs 14.4%).

United Asset Management was an American holding company headquartered in Boston, Massachusetts.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

AAMI vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.1× larger
RGEN
$197.9M
$172.2M
AAMI
Growing faster (revenue YoY)
RGEN
RGEN
+11.0% gap
RGEN
13.6%
2.6%
AAMI
Higher net margin
AAMI
AAMI
13.4% more per $
AAMI
20.2%
6.7%
RGEN
Faster 2-yr revenue CAGR
AAMI
AAMI
Annualised
AAMI
27.6%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AAMI
AAMI
RGEN
RGEN
Revenue
$172.2M
$197.9M
Net Profit
$34.7M
$13.3M
Gross Margin
52.5%
Operating Margin
33.3%
9.0%
Net Margin
20.2%
6.7%
Revenue YoY
2.6%
13.6%
Net Profit YoY
-18.4%
143.9%
EPS (diluted)
$0.97
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AAMI
AAMI
RGEN
RGEN
Q4 25
$172.2M
$197.9M
Q3 25
$144.2M
$188.8M
Q2 25
$127.4M
$182.4M
Q1 25
$119.9M
$169.2M
Q4 24
$167.8M
$174.1M
Q3 24
$123.1M
$154.9M
Q2 24
$109.0M
$154.1M
Q1 24
$105.7M
$151.3M
Net Profit
AAMI
AAMI
RGEN
RGEN
Q4 25
$34.7M
$13.3M
Q3 25
$15.1M
$14.9M
Q2 25
$10.1M
$14.9M
Q1 25
$20.1M
$5.8M
Q4 24
$42.5M
$-30.3M
Q3 24
$16.9M
$-654.0K
Q2 24
$11.0M
$3.3M
Q1 24
$14.6M
$2.1M
Gross Margin
AAMI
AAMI
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
AAMI
AAMI
RGEN
RGEN
Q4 25
33.3%
9.0%
Q3 25
18.4%
8.9%
Q2 25
12.7%
7.6%
Q1 25
26.6%
3.9%
Q4 24
38.7%
-17.7%
Q3 24
21.9%
-5.1%
Q2 24
18.9%
1.0%
Q1 24
21.7%
1.3%
Net Margin
AAMI
AAMI
RGEN
RGEN
Q4 25
20.2%
6.7%
Q3 25
10.5%
7.9%
Q2 25
7.9%
8.2%
Q1 25
16.8%
3.4%
Q4 24
25.3%
-17.4%
Q3 24
13.7%
-0.4%
Q2 24
10.1%
2.2%
Q1 24
13.8%
1.4%
EPS (diluted)
AAMI
AAMI
RGEN
RGEN
Q4 25
$0.97
$0.24
Q3 25
$0.42
$0.26
Q2 25
$0.28
$0.26
Q1 25
$0.54
$0.10
Q4 24
$1.11
$-0.55
Q3 24
$0.45
$-0.01
Q2 24
$0.29
$0.06
Q1 24
$0.37
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AAMI
AAMI
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$200.0M
$542.2M
Stockholders' EquityBook value
$2.1B
Total Assets
$677.0M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AAMI
AAMI
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Q1 24
$780.6M
Total Debt
AAMI
AAMI
RGEN
RGEN
Q4 25
$200.0M
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$275.0M
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
AAMI
AAMI
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.0B
Q1 24
$2.0B
Total Assets
AAMI
AAMI
RGEN
RGEN
Q4 25
$677.0M
$2.9B
Q3 25
$751.4M
$2.9B
Q2 25
$672.3M
$2.9B
Q1 25
$677.3M
$2.9B
Q4 24
$703.2M
$2.8B
Q3 24
$555.2M
$2.8B
Q2 24
$533.1M
$2.9B
Q1 24
$544.9M
$2.8B
Debt / Equity
AAMI
AAMI
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AAMI
AAMI
RGEN
RGEN
Operating Cash FlowLast quarter
$-2.4M
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
-0.07×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AAMI
AAMI
RGEN
RGEN
Q4 25
$-2.4M
$25.7M
Q3 25
$-23.9M
$48.1M
Q2 25
$61.6M
$28.6M
Q1 25
$-48.8M
$15.0M
Q4 24
$55.8M
$39.2M
Q3 24
$69.6M
$49.3M
Q2 24
$45.7M
$42.2M
Q1 24
$-40.4M
$44.7M
Free Cash Flow
AAMI
AAMI
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
Q1 24
$36.4M
FCF Margin
AAMI
AAMI
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Q1 24
24.0%
Capex Intensity
AAMI
AAMI
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Q1 24
5.5%
Cash Conversion
AAMI
AAMI
RGEN
RGEN
Q4 25
-0.07×
1.93×
Q3 25
-1.58×
3.23×
Q2 25
6.10×
1.92×
Q1 25
-2.43×
2.57×
Q4 24
1.31×
Q3 24
4.12×
Q2 24
4.15×
12.70×
Q1 24
-2.77×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons